Germline Testing identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors.
Mohindroo C, Baydogan S, Agarwal P, Wright RD, Prakash LR, Mork ME, Klein AP, Laheru DA, Maxwell JE, Katz MHG, Dasari A, Kim MP, He J, McAllister F, De Jesus-Acosta A.
Mohindroo C, et al. Among authors: wright rd.
Cancer Prev Res (Phila). 2024 Apr 25. doi: 10.1158/1940-6207.CAPR-23-0483. Online ahead of print.
Cancer Prev Res (Phila). 2024.
PMID: 38662083